Loading insider details...
Latest Form 4 (Jul 10, 2026): Grant/Award of 6,500 MCRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 6,500 | n/a |
| Feb 28, 2026 | WATERS CORP /DE/ (WAT) | Grant/Award | 358 | n/a |
| Sep 11, 2025 | BECTON DICKINSON & CO (BDX) | Sale | 917 | $171.9K |
| Aug 8, 2025 | BECTON DICKINSON & CO (BDX) | Sale | 863 | $166.0K |
| Jul 2, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 6,452 | n/a |
| Apr 11, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 100,000 | n/a |
| Jan 30, 2025 | BECTON DICKINSON & CO (BDX) | Grant/Award | 930 | n/a |
| Apr 8, 2024 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 60,000 | n/a |
| Jan 25, 2024 | BECTON DICKINSON & CO (BDX) | Grant/Award | 900 | n/a |
| Aug 30, 2023 | BECTON DICKINSON & CO (BDX) | Sale | 848 | $238.8K |